5G in Healthcare Market

5G in Healthcare Market by Component (Hardware, Connectivity, Services) Application (Remote Patient Monitoring, Connected Medical Devices, AR/VR, Connected Ambulance, Asset Tracking) End User (Healthcare Providers, Payers) - Global Forecast to 2026

Report Code: HIT 7990 Oct, 2021, by marketsandmarkets.com

[211 Pages Report] 5G stands for the fifth generation of mobile communication technology. With each generation’s new technology and standards, there have been improvements in transmission speed and network capacity. 5G represents a big leap in cellular technology and in healthcare by providing essential levels of connectivity to enable a new health ecosystem, one that can meet the needs of patients and providers accurately, efficiently, cost-effectively, conveniently, and at a substantial scale. This massive network will include billions of low-bitrates and low-energy connected health monitoring devices, remote sensors, and clinical wearables, with 5G providing a backbone infrastructure for IoT.

The 5G in healthcare market is valued at an estimated USD 215 million in 2021 and is projected to reach USD 3,667 million by 2026, at a CAGR of 76.3% during the forecast period. The increasing adoption of telehealth and robotics surgery due to COVID-19 and the rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring are key factors driving the growth of this market. The ability of 5G technology to transmit large patient data files quickly, advancements in telecommunication, and the availability of low-cost sensors are other major factors that are driving the growth of this market. However, the high cost of deployment of the 5G network is expected to restrain the growth of this market.

In this report, the 5G in healthcare market is segmented into component, application, end user, and region.

5G in Healthcare Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the 5G in healthcare Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. Traditional technologies in the medical field have failed to control this pandemic. Scholars, policymakers, and practitioners are searching for new technologies to control the outbreak. Timely accurate information and measures are necessary for practitioners and healthcare settings as they seek ways to assist in managing this pandemic. Advanced digital technology could be a key tool to control the rapid transmission, provide treatment, and develop medicines and vaccines. Access to information could also make people more aware of the steps needed for preparation for protection against and prevention of COVID-19. Only the available advanced technologies can ensure people’s access to COVID-19-related information. According to many scholars, COVID-19-related information should be made available to people using advanced digital technologies, comprising big data, artificial intelligence, deep learning, the internet of things, 5G, and 6G. These technologies are necessary to solve the main clinical problems as well as remove barriers to people’s access to information.

5G network could transform and improve all the critical components of healthcare, a subject especially meaningful today as the spread of the coronavirus has put unprecedented stress on healthcare systems across the globe. The much-awaited fifth generation of cellular wireless technology can revolutionize healthcare with its high speed and massive connection power. Along with its many primary advantages, it will also empower medical innovations via extended reality (augmented/virtual/mixed reality), artificial intelligence, remote medical learning, patient care, and monitoring, to name a few. The healthcare domain’s critical and time-sensitive nature makes it even more essential to have continuous access to near real-time data to support and derive full use of the advanced technologies today. The applications of 5G in healthcare assures better and effective communications, efficient and quick transmission of large amounts of data for early diagnosis of life-threatening diseases, coupled with low latency and high computing power to enhance and accelerate the growth of diagnosis and therapy exponentially. Such applications of 5G technology would also be of great assistance when dealing with the unprecedented impact of COVID-19 on healthcare systems worldwide.

5G and the related applications are currently under debate. One of the key motivations is to advance 5G communication and IoT from a social and humanitarian point of view, i.e., to integrate the communication systems which will help enhance the quality of life of people. It can help to improve the smart healthcare systems’ strong communication infrastructure in terms of reliability, stability of connections, accessibility, scalability of the network, and rapid response flexibility, enabling monitoring and preventive action to be taken in pandemic situations. Telehealth is an effective approach to ensure better healthcare and train medical professionals. Deep learning can also be considered as an approach for ensuring better health services through the latest technology - 5G. Wireless communication technologies can help to monitor the spread of viruses, aiding to improve the health and treatment processes. In disaster scenarios, hospitals are burdened with overwhelming patient admissions. Minimizing the physical contact between treatment seekers and physicians is an effective way to avoid this problem. Using IoMT products and robots in hospital and diagnostic centers will help reduce a hospital’s burden.

Remote healthcare is being promoted with the emergence of COVID-19 to reduce infection transmission and the load of patients at hospital premises. Remote services are dependent on physical infrastructure for 4G and 5G communication. 5G networks offer better services with significant progress compared to earlier generations. The vision of 5G is to use intelligence-based communication tools to turn the world into a safe and interlinked digital society.

In May 2020, the China-Japan Friendship Hospital was the first to deploy 5G digital indoor networks of China Telecom, China Mobile, and China Unicom, laying a solid foundation for exploration into and application of 5G telemedicine services. The China-Japan Friendship Hospital has been leveraging 5G to provide cloud visits and other patient services as well as assisting more than 5,000 hospitals across China through remote healthcare. Its 5G remote consultation system has been used by many hospitals to conduct remote consultations, CT examinations, and type-B ultrasounds, helping them treat COVID-19 patients more efficiently. In August 2020, China's top health regulatory body launched a standardization project, requesting the China-Japan Friendship Hospital to lead research that standardizes 5G applications in the medical industry. Other major participants include major hospitals, research institutes, and leading 5G players. This will enable China to build 5G medical networks against unified standards to foster 5G medical innovation, standardize the development of 5G medical terminals, and develop more valuable applications, further consolidating the infrastructure of smart hospitals.

5G has generated a buzz due to the capabilities of the technology itself, potential use cases, and its ability to catalyze a chain reaction of digital transformation. Those within the healthcare industry feel that 5G and the hype around it will help drive the innovation, adoption, and implementation of new technologies and solutions.

5G in healthcare  Market Dynamics

Drivers:Increasing adoption of telehealth and robotics surgery due to COVID-19

ICT and medical expertise have been a powerful combination for enhancing patient care for many years. Remote diagnosis and robotic-assisted surgery are commonly used across the globe, and the rapid pace at which ICT is evolving means that even greater possibilities for these techniques are becoming a reality.

Telemedicine requires a network that can support real-time high-quality video, which often means wired networks. According to a report by Frost & Sullivan, telehealth will grow sevenfold by 2025, with a compounded annual growth rate of 38.2%, parallel with the emergence and rollout of 5G.

Several countries have shown growing support for telemedicine and telehealth and are beginning to establish statewide telehealth coverage, defined reimbursement policies, and a legal framework for telehealth practices. For instance, in April 2019, the Centers for Medicare & Medicaid Services (CMS) announced and finalized changes in Medicare’s telehealth policy to enable remote patient monitoring for patients to access the latest technology and improve the coordination of healthcare processes. Furthermore, due to the pandemic, healthcare delivery changed significantly. Hospitals and doctors’ offices became potential exposure zones with patients needing urgent care. As a result, telemedicine became the primary option for patients needing care. The high standard of virtual care, coupled with the presence of 5G and its significant potential, healthcare delivery will transform to great levels. In the aftermath of the coronavirus pandemic, the 5G Enhanced Mobile Broadband (eMBB) technology will enable remote support of quality healthcare while reducing patient exposure to contagion by minimizing in-person visits to doctor or healthcare facilities. For patients who cannot easily travel to their healthcare providers, 5G will allow the provider to visit them via telepresence systems.

Robotic-assisted laser surgery is another area that can benefit from such developments. With the aid of a machine, doctors can now perform complex procedures with greater precision and flexibility and minimize the invasiveness of the operation. This is possible through 5G technology, which has helped in advances in software and seamless transmission of information. Many telecom giants are adopting this technology to transform their healthcare systems. For instance, in November 2019, Vodafone conducted a remote surgery operation for the first time in Italy through a live 5G network in collaboration with the Italian Institute of Technology (IIT) and the IRCSS Hospital San Raffaele. The surgery was performed from the theatre stage of the Vodafone Village, owing to benefits like extremely low latency and a high degree of reliability provided by 5G. This gives us a future outlook of healthcare, making medical and surgical expertise available on an ever-greater scale and eliminating geographical barriers. The benefits provided by 5G have further added to the increasing adoption of telehealth solutions.

Restraints: High cost of deployment of the 5G network

The transition from 4G to 5G technology would result in huge investments. The cost of the 5G infrastructure depends heavily on the required throughput density, periodic interest rate, and base station price. The reduction of these costs is important for effective and ultra-dense small cell deployments. The challenge for CSPs in transitioning to 5G is to justify the multibillion dollars of investments in new network equipment required to transform their network to a virtualized infrastructure, move services from 3G and 4G to 5G, all while protecting their business against the ever-increasing risks of disruptions and cyber threats. The transition to a standalone model is essential for telcos to capitalize on the full range of benefits that 5G offers. Their ability to successfully capture enterprise customers with low latency applications will require a distributed, standalone network with an edge compute platform, network slicing, and control/user plane separation. The current standalone deployments have helped telcos quickly work upon their 5G rollout plans that are focused on delivering fixed and mobile broadband services to consumers.

Opportunities: Role of AI in 5G healthcare

An AI-powered, real-time remote monitoring solution enables caregivers to passively detect changes in conditions, reduce hospitalizations, and improve quality metrics. AI and 5G-enabled devices track users’ daily living activities using novel gesture-detection algorithms and provide insights and predictive analytics around them, including sleep quality, fall risk, fall detection, drinking/hydration, activity patterns, wandering, and UTI risk. These data deliver important clinical insights to healthcare providers, helping them maintain continuous contact with and improve the well-being of those under their care. Internet of Things (IoT)-enabled medical devices and AI-powered data analysis can streamline health monitoring and create a fully “connected” hospital. IoT can also aid in driving greater efficiencies in auxiliary functions such as logistics and supply chain.

Apps and wearables based on AI can leverage 5G and machine learning for health-related data analysis of medical diagnosis and emergency care. Many key healthcare functions are beginning to use artificial intelligence (AI) to determine potential diagnoses and decide on the best treatment plan for a specific patient. Additionally, AI can help predict which patients are more likely to have postoperative complications, allowing healthcare systems to provide early interventions when necessary. By moving to 5G networks, healthcare organizations can use the AI tools they need to provide the best care possible.

Challenges: Data breach and security concerns

Increased use of automated healthcare technologies offers greater reach and efficiency in healthcare delivery but has high-security risks due to the broader access offered. Approximately one-third of data breaches result in medical identity theft in the healthcare industry, mainly due to the lack of internal control over patient information, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training.

5G brings together applications that are dependent on data moving very quickly in a real-time environment. However, it is not just about faster speeds to the smartphone; it is about connecting devices and machines to each other. But integrating these devices to one another comes with its own set of concerns.

In the US, the HIPAA Journal recorded 616 healthcare data breaches in its 2020 breach list, an increase of 66% over the total number of breaches tracked in 2018. According to a publication from HIPAA Journal, HIPAA-covered companies and business associates paid around USD 13.6 million for HIPAA violations in 2020 and around USD 15.3 million in 2019. Thus, creating a secure communication platform is a major challenge faced by IT vendors catering to the healthcare industry. Potential security concerns related to healthcare IT systems may lead to a rise in the sense of insecurity among users and, hence, restrict their adoption until secure 5G related solutions are available in the market.

“The Hardware segment accounted for the largest market share in 2020.”

Based on component, the 5G in healthcare market is segmented into hardware, services, and connectivity. The hardware segment accounted for the largest share of the 5G in healthcare market in 2020. This segment is projected to reach USD 1,871.7 million by 2026, at a CAGR of 76.0% during the forecast period. The large share of this segment can primarily be attributed to the need for frequent upgradation or replacement to make optimal use of the latest software available in the market.

 “The Connected Medical Devices segment accounted for the largest market share in 2020.”

Based on application, the 5G in healthcare market is segmented into remote patient monitoring, connected ambulance, connected medical devices, asset tracking for medical devices, and AR/VR. The connected medical devices segment accounted for the largest share of the 5G in healthcare market in 2020. This application segment is projected to reach USD 1,405.3 million by 2026 from USD 94.5 million in 2021, at a CAGR of 71.6% during the forecast period. The large share of this segment can be attributed to the growth in the telehealth market and the growing inclination towards home healthcare. The high burden of COVID-19, increasing healthcare costs, strong government support and initiatives, and the growing focus on the quality of care and patient safety are further driving the market for connected medical devices in the 5G in healthcare market.

 “The Healthcare Providers  segment accounted for the largest market share in 2020.”

Based on end users, the 5G in healthcare market is segmented into healthcare providers, healthcare payers, and other end users. The healthcare providers segment accounted for the largest share of the 5G in healthcare market in 2020. This end-user segment is projected to reach USD 3,011.1 million by 2026 from USD 170.4 million in 2021, at a CAGR of 77.6% during the forecast period. The large share of this segment can be attributed to the rising need for an efficient healthcare system, growing patient volume, increasing number of hospitals and ambulatory care centers, growth in telehealth, rising adoption of 5G-enabled wearable medical devices, and the rising demand for better technologies that help in the easy transfer of large data files.

“Asia Pacific was the largest regional market for 5G in healthcare market in 2020“

The global 5G in healthcare market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, Asia Pacific accounted for the largest share of 33.8% of the global market. The APAC is the largest and fastest-growing region in the 5G in healthcare market. This growth can be attributed to the significant adoption of advanced technologies, increasing number of IoT-enabled medical devices, continuously enhancing network connectivity, and government initiatives for IoT.

5G in Healthcare Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Prominent players in the 5G in healthcare market include AT&T (US), Verizon (US), China Mobile Limited (China), T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone (UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany), Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India), Huawei Technologies Co., Ltd. (China), Cisco (US), Sierra Wireless (Canada), Swisscom (Switzerland), Qualcomm (US), Fibocom Wireless Inc. (China), Quectel (China), and Sequans (France) These companies adopted strategies such as service launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the 5G in healthcare market.

Scope of Report

Report Metric

Details

Market size available for years

2019-2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD)

Segments covered

By Component, Application, End User and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies covered

The major market players include AT&T (US), Verizon (US), China Mobile Limited (China), T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone (UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany), Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India), Huawei Technologies Co., Ltd. (China), Cisco (US), Sierra Wireless (Canada), Swisscom (Switzerland), Qualcomm (US), Fibocom Wireless Inc. (China), Quectel (China), and Sequans (France)

The study categorizes the 5G in healthcare based on By Component, Application and End User at the regional and global level.

By Component

  • Hardware
  • Services
  • Connectivity

By Application

  • Connected Medical Devices
  • Remote Patient Monitoring
  • AR/VR
  • Asset tracking for medical devices
  • Connected Ambulance

By End Users

  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Recent Developments

  • In January 2019, Rush University Medical Center partnered with AT&T (US) to bring the latest mobile communications technology to clinical care based on 5G to improve communications, data processing needs, and the patient experience.
  • In May 2019, Ooredoo (Qatar) worked with Ericsson (Sweden) to leverage 5G technology in ambulances to allow doctors to treat patients remotely by controlling a special haptic glove worn by the paramedic on the scene.
  • In February 2020, Emory Healthcare partnered with Verizon (US). Emory Healthcare is using Verizon’s 5G Ultra-Wideband to enhance augmented reality and virtual reality (AR/VR) applications for medical training, telemedicine, and remote monitoring, in addition to diagnostic and imaging systems from ambulances to ER.
  • In January 2020, China Telecom (China), ZTE (China), and West China hospital are facilitating the remote diagnosis of coronavirus via 5G.
  • In June 2020, ZTE (China), along with Huawei (China), built  5G demo sites for remote consultation and outpatient & image diagnosis.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
          TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION: 5G IN HEALTHCARE MARKET
          FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE FROM 5G IOT VENDORS
          FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY (DEMAND SIDE): DEMAND-SIDE MARKET ESTIMATIONS THROUGH APPLICATION/USE CASES
          FIGURE 8 CAGR PROJECTIONS: OVERALL 5G IN HEALTHCARE MARKET
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: 5G IN HEALTHCARE MARKET
    2.7 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 10 5G IN HEALTHCARE MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 5G IN HEALTHCARE MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 5G IN HEALTHCARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE 5G IN HEALTHCARE MARKET

4 PREMIUM INSIGHTS (Page No. - 47)
    4.1 5G IN HEALTHCARE MARKET OVERVIEW
          FIGURE 14 RISING ADOPTION OF 5G-ENABLED WEARABLE MEDICAL DEVICES FOR REAL-TIME REMOTE PATIENT MONITORING TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: 5G IN HEALTHCARE MARKET, BY END USER AND COUNTRY (2020)
          FIGURE 15 HEALTHCARE PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020
    4.3 5G IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 16 JAPAN TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    4.4 REGIONAL MIX: 5G IN HEALTHCARE MARKET (2019−2026)
          FIGURE 17 ASIA PACIFIC WILL DOMINATE THE 5G IN HEALTHCARE MARKET DURING THE FORECAST PERIOD
    4.5 5G IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of telehealth and robotics surgery due to COVID-19
                    5.2.1.2 Rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring
                                FIGURE 19 SMARTPHONE USERS AND PENETRATION WORLDWIDE, 2016–2021
                    5.2.1.3 Ability of 5G technology to transmit large patient data files quickly
                    5.2.1.4 Advancements in telecommunication
                    5.2.1.5 Availability of low-cost sensors
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of deployment of the 5G network
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Role of AI in 5G healthcare
                    5.2.3.2 High reliability and low latency 5G networks to accelerate a new wave of healthcare applications
           5.2.4 CHALLENGES
                    5.2.4.1 Delay in spectrum harmonization across geographies
                    5.2.4.2 Data breach and security concerns
                               FIGURE 20 US: NUMBER OF DATA BREACHES (2005–2020)

6 INDUSTRY INSIGHTS (Page No. - 58)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 RISING DEMAND FOR 5G TECHNOLOGY ACROSS THE HEALTHCARE CONTINUUM
                    FIGURE 21 TELECOM OPERATOR REVENUE POTENTIAL IN ADDRESSING HEALTHCARE INDUSTRY DIGITALIZATION WITH 5G IN 2026
           6.2.2 5G-ENABLED INTERNET OF MEDICAL THINGS (IMOT)
                    FIGURE 22 5G HEALTHCARE USE CASES
           6.2.3 5G-ENABLED HEALTHCARE TRAINING AND THERAPEUTIC & REHABILITATIVE USES FOR AR/VR
           6.2.4 PRIVATE 5G NETWORKS
    6.3 TECHNOLOGY ANALYSIS
           6.3.1 INTRODUCTION
                    FIGURE 23 COMPARISON OF 5G TECHNOLOGY SPECIFICATIONS TO OTHER WIRELESS PROTOCOLS
           6.3.2 WI-FI
           6.3.3 WIMAX
           6.3.4 NETWORK SLICING IN RADIO ACCESS NETWORK
           6.3.5 NETWORK SLICING IN CORE NETWORK
           6.3.6 NETWORK SLICING IN TRANSPORT NETWORK
           6.3.7 SMALL CELL NETWORKS
           6.3.8 LONG-TERM EVOLUTION NETWORKS
           6.3.9 CITIZENS BROADBAND RADIO SERVICES
           6.3.10 MULTEFIRE
    6.4 REGULATORY IMPLICATIONS
           6.4.1 GENERAL DATA PROTECTION REGULATION
           6.4.2 CALIFORNIA CONSUMER PRIVACY ACT
           6.4.3 PAYMENT CARD INDUSTRY DATA SECURITY STANDARD
           6.4.4 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT
           6.4.5 DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE
           6.4.6 HEALTH LEVEL SEVEN
           6.4.7 GRAMM-LEACH-BLILEY ACT
           6.4.8 SARBANES-OXLEY ACT
           6.4.9 SOC 2
           6.4.10 COMMUNICATIONS DECENCY ACT
           6.4.11 DIGITAL MILLENNIUM COPYRIGHT ACT
           6.4.12 ANTI-CYBERSQUATTING CONSUMER PROTECTION ACT
           6.4.13 LANHAM ACT
    6.5 PRICING ANALYSIS
          TABLE 4 5G IN HEALTHCARE MARKET: PRICING ANALYSIS
    6.6 CASE STUDY ANALYSIS
           6.6.1 CHINA MOBILE LIMITED
           6.6.2 AT&T
    6.7 ECOSYSTEM ANALYSIS
          TABLE 5 5G IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
          FIGURE 24 5G IN HEALTHCARE MARKET: ECOSYSTEM MARKET MAP
           6.7.1 5G TELECOM OPERATORS
           6.7.2 5G MOBILE SENSOR/CHIPSET TECHNOLOGY PROVIDERS
           6.7.3 5G MOBILE DEVICE MANUFACTURERS
           6.7.4 END USER/APPLICATION/USE CASES
    6.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 6 PORTER’S FIVE FORCES ANALYSIS
           6.8.1 INTENSITY OF COMPETITIVE RIVALRY
    6.9 COVID-19 IMPACT ON THE 5G IN HEALTHCARE MARKET
    6.10 PATENT ANALYSIS
           TABLE 7 PATENTS IN 5G IN HEALTHCARE MARKET
           FIGURE 25 TOTAL NO. OF PATENTS FILED BY PLAYERS
           FIGURE 26 FILING TREND

7 5G IN HEALTHCARE MARKET, BY COMPONENT (Page No. - 78)
    7.1 INTRODUCTION
          TABLE 8 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
    7.2 HARDWARE
           7.2.1 HARDWARE IS THE LARGEST COMPONENT SEGMENT OF THE 5G IN HEALTHCARE MARKET
                     TABLE 9 5G IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 SERVICES
           7.3.1 SERVICES HELP END USERS EFFECTIVELY DESIGN AND OPERATE NETWORK INFRASTRUCTURE TO GAIN DESIRABLE BUSINESS OUTCOMES
           7.3.2 PROFESSIONAL SERVICES
           7.3.3 MANAGED SERVICES
                     TABLE 10 5G IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 CONNECTIVITY
           7.4.1 5G CONNECTIVITY TO BRING STRONG FOUNDATION FOR INTERNET OF THINGS USE CASES
                     TABLE 11 5G IN HEALTHCARE MARKET FOR CONNECTIVITY, BY COUNTRY, 2019–2026 (USD MILLION)

8 5G IN HEALTHCARE MARKET, BY APPLICATION (Page No. - 84)
    8.1 INTRODUCTION
          TABLE 12 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 CONNECTED MEDICAL DEVICES
           8.2.1 CONNECTED MEDICAL DEVICES IS THE LARGEST APPLICATION SEGMENT OF THE 5G IN HEALTHCARE MARKET
                     TABLE 13 5G IN HEALTHCARE MARKET FOR CONNECTED MEDICAL DEVICES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 REMOTE PATIENT MONITORING
           8.3.1 PATIENT READMISSION RATE HAS BEEN REDUCING DUE TO THE AVAILABILITY OF PATIENT MONITORING KITS AT HIGH-SPEED 5G CONNECTIVITY
                     TABLE 14 5G IN HEALTHCARE MARKET FOR REMOTE PATIENT MONITORING, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 ASSET TRACKING FOR MEDICAL DEVICES
           8.4.1 5G IOT ENABLES HEALTHCARE COMPANIES TO DEPLOY EFFICIENT IOT APPLICATIONS, WHICH HELPS THEM TRACK THEIR ASSETS IN REAL-TIME
                     TABLE 15 5G IN HEALTHCARE MARKET FOR ASSET TRACKING FOR MEDICAL DEVICES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.5 AR/VR
           8.5.1 5G-POWERED AR AND VR ENABLES HEALTHCARE PROVIDERS TO VISUALIZE PROCEDURES IN AN ENGAGING, LEARNING-BY-DOING PRACTICE THAT WILL ENHANCE THEIR MEDICAL EDUCATION
                     TABLE 16 5G IN HEALTHCARE MARKET FOR AR/VR, BY COUNTRY, 2019–2026 (USD MILLION)
    8.6 CONNECTED AMBULANCE
           8.6.1 CONNECTED AMBULANCE IS EMPOWERED BY 5G’S HIGH BANDWIDTH, LOW LATENCY, AND ULTRA-RELIABLE CONNECTIVITY
                     TABLE 17 5G IN HEALTHCARE MARKET FOR CONNECTED AMBULANCE, BY COUNTRY, 2019–2026 (USD MILLION)

9 5G IN HEALTHCARE MARKET, BY END USER (Page No. - 92)
    9.1 INTRODUCTION
          TABLE 18 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 HEALTHCARE PROVIDERS
           9.2.1 RISING NEED TO IMPROVE THE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST THE USE OF 5G IN HEALTHCARE
                    TABLE 19 5G IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.3 HEALTHCARE PAYERS
           9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE THE DEMAND FOR 5G IN HEALTHCARE
                    TABLE 20 5G IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
    9.4 OTHER END USERS
          TABLE 21 5G IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

10 5G IN HEALTHCARE MARKET, BY REGION (Page No. - 97)
     10.1 INTRODUCTION
             TABLE 22 5G IN HEALTHCARE MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 ASIA PACIFIC
             FIGURE 27 ASIA PACIFIC: 5G IN HEALTHCARE MARKET SNAPSHOT
             TABLE 23 APAC: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 24 APAC: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 25 APAC: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 26 APAC: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 CHINA
                        10.2.1.1 China dominates the APAC 5G in healthcare market
                                     TABLE 27 CHINA: MACROECONOMIC INDICATORS
                                     TABLE 28 CHINA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 29 CHINA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 30 CHINA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 JAPAN
                        10.2.2.1 Japan has a strong base of technologically advanced healthcare verticals that offer multiple opportunities for the growth of the 5G network
                                     TABLE 31 JAPAN: MACROECONOMIC INDICATORS
                                     TABLE 32 JAPAN: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 33 JAPAN: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 34 JAPAN: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.3 SOUTH KOREA
                        10.2.3.1 Increased spending on geriatric health and coverage for major chronic diseases to support market growth in South Korea
                                     TABLE 35 SOUTH KOREA: MACROECONOMIC INDICATORS
                                     TABLE 36 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 37 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 38 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.4 AUSTRALIA
                        10.2.4.1 Favorable R&D tax benefits offered in the country to drive market growth
                                     TABLE 39 AUSTRALIA: MACROECONOMIC INDICATORS
                                     TABLE 40 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 41 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 42 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.5 REST OF ASIA PACIFIC
                       TABLE 43 ROAPAC: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                       TABLE 44 ROAPAC: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 45 ROAPAC: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 NORTH AMERICA
             FIGURE 28 NORTH AMERICA: 5G IN HEALTHCARE MARKET SNAPSHOT
             TABLE 46 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 47 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 48 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 49 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 US
                        10.3.1.1 The US dominates the North American 5G in healthcare market
                                     TABLE 50 US: MACROECONOMIC INDICATORS
                                     TABLE 51 US: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 52 US: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 53 US: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 CANADA
                        10.3.2.1 Deployment of digital services to drive market growth
                                     TABLE 54 CANADA: MACROECONOMIC INDICATORS
                                     TABLE 55 CANADA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 56 CANADA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 57 CANADA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.4 EUROPE
             TABLE 58 EUROPE: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 59 EUROPE: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
             TABLE 60 EUROPE: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 61 EUROPE: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 GERMANY
                        10.4.1.1 Germany accounted for the largest share of the European 5G in healthcare market in 2020
                                     TABLE 62 GERMANY: MACROECONOMIC INDICATORS
                                     TABLE 63 GERMANY: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 64 GERMANY: 5G IN HEALTHCARE MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
                                     TABLE 65 GERMANY: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 UK
                        10.4.2.1 Government initiatives favoring the adoption of digitalization to drive market growth
                                     TABLE 66 UK: MACROECONOMIC INDICATORS
                                     TABLE 67 UK: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                                     TABLE 68 UK: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                     TABLE 69 UK: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 REST OF EUROPE
                        TABLE 70 ROE: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 71 ROE: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 72 ROE: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 5G IN HEALTHCARE MARKET IN LATIN AMERICA IS IN THE NASCENT PHASE AND IS EXPECTED TO GROW AT A STEADY RATE IN THE FORECAST PERIOD
                        TABLE 73 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 74 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 75 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 RISING DEMAND FOR BETTER TECHNOLOGY-ENABLED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
                        TABLE 76 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
                        TABLE 77 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                        TABLE 78 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 132)
     11.1 INTRODUCTION
             FIGURE 29 KEY DEVELOPMENTS BY MAJOR PLAYERS BETWEEN JANUARY 2018 AND AUGUST 2021
     11.2 COMPETITIVE BENCHMARKING
             11.2.1 COMPONENT FOOTPRINT OF COMPANIES
             11.2.2 REGIONAL FOOTPRINT OF COMPANIES
     11.3 5G IN HEALTHCARE MARKET: R&D EXPENDITURE
             FIGURE 30 R&D EXPENDITURE OF KEY PLAYERS IN THE 5G IN HEALTHCARE MARKET (2019 VS. 2020)
     11.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS
             FIGURE 31 5G IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY MARKET PLAYERS (2020)
     11.5 COMPETITIVE LEADERSHIP MAPPING
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 32 COMPETITIVE LEADERSHIP MAPPING: 5G IN HEALTHCARE MARKET, 2020
     11.6 MARKET RANKING ANALYSIS
             FIGURE 33 5G IN HEALTHCARE MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020
     11.7 COMPETITIVE SITUATION AND TRENDS
             11.7.1 COMPONENT LAUNCHES
             11.7.2 DEALS
             11.7.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 142)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 AT&T
                        TABLE 79 AT&T: BUSINESS OVERVIEW
                        FIGURE 34 AT&T: COMPANY SNAPSHOT (2020)
             12.1.2 VERIZON
                        TABLE 80 VERIZON: BUSINESS OVERVIEW
                        FIGURE 35 VERIZON: COMPANY SNAPSHOT (2020)
             12.1.3 ERICSSON
                        TABLE 81 ERICSSON: BUSINESS OVERVIEW
                        FIGURE 36 ERICSSON: COMPANY SNAPSHOT (2020)
             12.1.4 T-MOBILE
                        TABLE 82 T-MOBILE: BUSINESS OVERVIEW
                        FIGURE 37 T-MOBILE: COMPANY SNAPSHOT (2020)
             12.1.5 CHINA MOBILE LIMITED
                        TABLE 83 CHINA MOBILE LIMITED: BUSINESS OVERVIEW
                        FIGURE 38 CHINA MOBILE LIMITED: COMPANY SNAPSHOT (2020)
             12.1.6 CISCO
                        TABLE 84 CISCO: BUSINESS OVERVIEW
                        FIGURE 39 CISCO: COMPANY SNAPSHOT (2020)
             12.1.7 TELUS
                        TABLE 85 TELUS: BUSINESS OVERVIEW
                        FIGURE 40 TELUS: COMPANY SNAPSHOT (2020)
             12.1.8 HUAWEI TECHNOLOGIES CO., LTD.
                        TABLE 86 HUAWEI TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 41 HUAWEI TECHNOLOGIES CO., LTD.: COMPANY SNAPSHOT (2020)
             12.1.9 TELIT
                        TABLE 87 TELIT: BUSINESS OVERVIEW
                        FIGURE 42 TELIT: COMPANY SNAPSHOT (2020)
             12.1.10 ORANGE S.A.
                        TABLE 88 ORANGE S.A.: BUSINESS OVERVIEW
                        FIGURE 43 ORANGE S.A.: COMPANY SNAPSHOT (2020)
             12.1.11 TELEFÓNICA
                        TABLE 89 TELEFÓNICA: BUSINESS OVERVIEW
                        FIGURE 44 TELEFÓNICA: COMPANY SNAPSHOT (2020)
             12.1.12 SK TELECOM CO., LTD.
                        TABLE 90 SK TELECOM CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 45 SK TELEKOM CO., LTD.: COMPANY SNAPSHOT (2020)
             12.1.13 SAMSUNG
                        TABLE 91 SAMSUNG: BUSINESS OVERVIEW
                        FIGURE 46 SAMSUNG: COMPANY SNAPSHOT (2020)
             12.1.14 BT GROUP
                        TABLE 92 BT GROUP: BUSINESS OVERVIEW
                        FIGURE 47 BT GROUP: COMPANY SNAPSHOT (2020)
             12.1.15 DEUTSCHE TELEKOM
                        TABLE 93 DEUTSCHE TELEKOM AG: BUSINESS OVERVIEW
                        FIGURE 48 DEUTSCHE TELEKOM AG: COMPANY SNAPSHOT (2020)
             12.1.16 VODAFONE
                        TABLE 94 VODAFONE: BUSINESS OVERVIEW
                        FIGURE 49 VODAFONE: COMPANY SNAPSHOT (2020)
             12.1.17 NOKIA
                        TABLE 95 NOKIA: BUSINESS OVERVIEW
                        FIGURE 50 NOKIA: COMPANY SNAPSHOT (2020)
             12.1.18 NEC CORPORATION
                        TABLE 96 NEC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 51 NEC CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.19 QUALCOMM
                        TABLE 97 QUALCOMM: BUSINESS OVERVIEW
                        FIGURE 52 QUALCOMM: COMPANY SNAPSHOT (2020)
             12.1.20 NTT DOCOMO
                        TABLE 98 NTT DOCOMO: BUSINESS OVERVIEW
                        FIGURE 53 NTT DOCOMO: COMPANY SNAPSHOT (2020)
     12.2 OTHER PLAYERS
             12.2.1 SIERRA WIRELESS
             12.2.2 QUECTEL
             12.2.3 FIBOCOM
             12.2.4 SWISSCOM
             12.2.5 SEQUANS
             12.2.6 AIRTEL

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 204)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities for estimating the current size of the 5G in healthcare market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, bottom-up and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the real-world evidence solutions market. Primary sources from the demand side include experts from pharma and biopharma companies, experts from food industry and research centers. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.

5G in Healthcare Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the real-world evidence solutions market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the 5G in healthcare market

The size of the 5G in healthcare market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global 5G in healthcare market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the global 5G in healthcare market based on component, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to the individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (along with the major countries in these regions)
  • To profile the key market players and comprehensively analyze their market shares and core competencies2 in the 5G in healthcare market
  • To track and analyze competitive developments such as business expansions, partnerships, agreements, collaborations, acquisitions, and product/service launches in the global 5G in healthcare market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies

Geographic Analysis

  • Further breakdown of the RoAPAC market into India, New Zealand, Hong Kong, Singapore, and other countries
  • Further breakdown of the RoE market into France, Italy, Russia, the Netherlands, Nordic countries, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the 5G in Healthcare Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the 5G in Healthcare Market

Request For Special Pricing
Report Code
HIT 7990
Published ON
Oct, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 5G in Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved